Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments

被引:176
作者
Robinson, Paul
Griffiths, Peter J.
Watkins, Hugh
Redwood, Charles S. [1 ]
机构
[1] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[2] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX3 7BN, England
关键词
cardiomyopathy; calcium; troponin; signaling;
D O I
10.1161/CIRCRESAHA.107.156380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated cardiomyopathy and hypertrophic cardiomyopathy (HCM) can be caused by mutations in thin filament regulatory proteins of the contractile apparatus. In vitro functional assays show that, in general, the presence of dilated cardiomyopathy mutations decreases the Ca(2+) sensitivity of contractility, whereas HCM mutations increase it. To assess whether this functional phenomenon was a direct result of altered Ca(2+) affinity or was caused by altered troponin - tropomyosin switching, we assessed Ca(2+) -binding of the regulatory site of cardiac troponin C in wild-type or mutant troponin complex and thin filaments using a fluorescent probe (2-[4'-{iodoacetamido}aniline]-naphthalene-6-sulfonate) attached to Cys35 of cardiac troponin C. The Ca(2+)-binding affinity (pCa(50) = 6.57 +/- 0.03) of reconstituted troponin complex was unaffected by all of the HCM and dilated cardiomyopathy troponin mutants tested, with the exception of the troponin I Arg145Gly HCM mutation, which caused an increase ( Delta pCa(50) = +0.31 +/- 0.05). However, when incorporated into regulated thin filaments, all but 1 of the 10 troponin and - tropomyosin mutants altered Ca(2+)-binding affinity. Both HCM mutations increased Ca(2+) affinity (Delta pCa(50) = +0.41 +/- 0.02 and + 0.51 +/- 0.01), whereas the dilated cardiomyopathy mutations decreased affinity (Delta pCa(50) = + 0.12 +/- 0.04 to - 0.54 +/- 0.04), which correlates with our previous functional in vitro assays. The exception was the troponin T Asp270Asn mutant, which caused a significant decrease in cooperativity. Because troponin is the major Ca(2+) buffer in the cardiomyocyte sarcoplasm, we suggest that Ca(2+) affinity changes caused by cardiomyopathy mutant proteins may directly affect the Ca(2+) transient and hence Ca(2+)-sensitive disease state remodeling pathways in vivo. This represents a novel mechanism for this class of mutation.
引用
收藏
页码:1266 / 1273
页数:8
相关论文
共 41 条
  • [1] Reviews of translational medicine and genomics in cardiovascular disease: New disease taxonomy and therapeutic implications - Cardiomyopathies: Therapeutics based on molecular phenotype
    Ashrafian, Houman
    Watkins, Hugh
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (12) : 1251 - 1264
  • [2] The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation
    Biesiadecki, Brandon J.
    Kobayashi, Tomoyoshi
    Walker, John S.
    Solaro, R. John
    de Tombe, Pieter P.
    [J]. CIRCULATION RESEARCH, 2007, 100 (10) : 1486 - 1493
  • [3] Mapping the interacting regions between troponins T and C - Binding of TnT and TnI peptides to TnC and NMR mapping of the TnT-binding site on TnC
    Blumenschein, TMA
    Tripet, BP
    Hodges, RS
    Sykes, BD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) : 36606 - 36612
  • [4] Bottinelli R, 1998, CIRC RES, V82, P106
  • [5] Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C
    Davis, Jonathan P.
    Norman, Catalina
    Kobayashi, Tomoyoshi
    Solaro, R. John
    Swartz, Darl R.
    Tikunova, Svetlana B.
    [J]. BIOPHYSICAL JOURNAL, 2007, 92 (09) : 3195 - 3206
  • [6] Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation
    Du, Cheng-Kun
    Morimoto, Sachio
    Nishii, Kiyomasa
    Minakami, Reiko
    Ohta, Mika
    Tadano, Naoto
    Lu, Qun-Wei
    Wang, Yuan-Yuan
    Zhan, Dong-Yun
    Mochizuki, Misato
    Kita, Satomi
    Miwa, Yoshikazu
    Takahashi-Yanaga, Fumi
    Iwamoto, Takahiro
    Ohtsuki, Iwao
    Sasaguri, Toshiyuki
    [J]. CIRCULATION RESEARCH, 2007, 101 (02) : 185 - 194
  • [7] Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy
    Elliott, K
    Watkins, H
    Redwood, CS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) : 22069 - 22074
  • [8] An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
    Fatkin, D
    McConnell, BK
    Mudd, JO
    Semsarian, C
    Moskowitz, IGP
    Schoen, FJ
    Giewat, M
    Seidman, CE
    Seidman, JG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) : 1351 - 1359
  • [9] Plasticity in skeletal cardiac, and smooth muscle -: Invited review:: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation
    Hernandez, OM
    Housmans, PR
    Potter, JD
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2001, 90 (03) : 1125 - 1136
  • [10] Folding and function of the troponin tail domain - Effects of cardiomyopathic troponin T mutations
    Hinkle, A
    Tobacman, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) : 506 - 513